News Articles Tagged: Carfilzomib Resistance

Hexamethylene Amiloride: In Vivo Anti-Myeloma Efficacy and Therapeutic Potential

Examine the in vivo effectiveness of Hexamethylene Amiloride (CAS 1428-95-1) against multiple myeloma, exploring its therapeutic potential and implications for combination treatments.

Hexamethylene Amiloride: A New Hope for Carfilzomib-Resistant Multiple Myeloma

Explore how Hexamethylene Amiloride (CAS 1428-95-1) is revolutionizing multiple myeloma treatment by overcoming carfilzomib resistance and inducing lysosome-mediated cell death. Learn more.